Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin

Autor:	Osonoi, Takeshi, Saito, Miyoko, Hariya, Natsuyo, Goto, Moritaka, Mochizuki, Kazuki
Zdroj:	In Peptides December 2016 86:118-125
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect